Welcome to our dedicated page for Evolent Health news (Ticker: EVH), a resource for investors and traders seeking the latest updates and insights on Evolent Health stock.
Evolent Health reports developments tied to its healthcare services business for people with complex conditions. Company news commonly covers operating and financial results, customer activity with health plans and providers, and the Performance Suite contract model used in its specialty care operations.
Recurring updates also include Evolent's complex specialty care focus in oncology, cardiology and musculoskeletal conditions, management participation in healthcare investor conferences, leadership appointments, board and compensation matters, and equity-award disclosures under NYSE rules.
Evolent Health, a healthcare company listed on NYSE as EVH, announced its participation in the 40th Annual Canaccord Genuity Growth Conference. CEO Frank Williams, President Seth Blackley, and CFO John Johnson will present on August 13, 2020, at 10:30 a.m. ET. A live webcast will be available on Evolent's investor relations website. Evolent Health is known for its clinical and administrative solutions that enhance healthcare affordability and quality, holding the first NCQA Population Health Program Accreditation.
Evolent Health (NYSE: EVH) reported significant findings in the July issue of The American Journal of Managed Care, indicating that remote health advising and care management interventions can markedly decrease hospitalizations and medical spending for high-risk Medicare beneficiaries. The study revealed that participating patients had a 21% reduction in inpatient admissions and a 22% decrease in total medical costs. Those deeply engaged in the program experienced even greater benefits, with 47% fewer readmissions and a 42% reduction in medical spending. The analysis followed nearly 1,900 high-risk participants over six months.
Evolent Health, Inc. (NYSE: EVH) will release its second quarter 2020 operating results on August 4, 2020, after market close. A conference call to discuss these results will occur at 5:00 p.m. Eastern Time on the same day. Interested parties can listen by dialing 855.940.9467 or 412.317.6034 for international calls, referencing the "Evolent Health call." An audio playback will be available on Evolent's investor relations website for one week post-call.
Evolent delivers clinical and administrative solutions aimed at improving health care affordability and simplicity.
Evolent Health (NYSE: EVH) announced a definitive agreement for Molina Healthcare to acquire certain assets of Passport Health Plan. The deal includes Passport's brand, operational infrastructure, and specific agreements, with Molina paying $20M upfront and up to $40M based on member retention in 2021. The implied total valuation for Passport, including statutory capital, is estimated between $150M and $190M. Evolent will continue to provide services to Passport through the end of 2020 and is set to offer specialty care management services in Kentucky starting in 2021.
Summary not available.